NCT05852678

Brief Summary

Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 22,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22,000

participants targeted

Target at P75+ for all trials

Timeline
231mo left

Started Apr 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Apr 2021Apr 2045

Study Start

First participant enrolled

April 20, 2021

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
21.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2045

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2045

Last Updated

May 12, 2023

Status Verified

April 1, 2023

Enrollment Period

24 years

First QC Date

May 2, 2023

Last Update Submit

May 11, 2023

Conditions

Chronic Disease

Keywords

LifestyleSocio-economic factorsBiobankBig dataPrecision medicineLongitudinal study

Outcome Measures

Primary Outcomes (5)

  • Integration and use of real-world data to improve health research

    20 years

  • Identifying lifestyle risk factors and their involvement in chronic diseases

    20 years

  • Evaluation of geographic and socio-economic disparities in health and healthcare

    20 years

  • Assessing biomarkers for the early detection of diseases and disease risks

    20 years

  • Surveillance of viral hepatitis and HIV in Cantabria

    20 years

Study Arms (1)

Patient registry

The Cantabria Cohort will recruit 40,000-50,000 residents aged 40-69 years at baseline

Other: cohort

Interventions

cohortOTHER

The Cantabria Cohort will recruit 40,000-50,000 residents aged 40-69 years at baseline

Patient registry

Eligibility Criteria

Age40 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Residents in the autonomous community of Cantabria

You may qualify if:

  • Participants between 40-69 years of age
  • Participants who sign the informed consent form
  • Participants legally residing in Cantabria

You may not qualify if:

  • Participants under 40 years of age and over 69 years of age
  • Participants not signing the informed consent form
  • Participants not legally residing in Cantabria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Marques de Valdecilla

Santander, 39011, Spain

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples will be used to measure conventional analytical parameters as well as serological markers of viral infection.

MeSH Terms

Conditions

Chronic Disease

Interventions

Cohort Studies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2023

First Posted

May 10, 2023

Study Start

April 20, 2021

Primary Completion (Estimated)

April 1, 2045

Study Completion (Estimated)

April 1, 2045

Last Updated

May 12, 2023

Record last verified: 2023-04

Locations

ES(1)